News & Events

23rd Annual Infectious Diseases Research Day / 10th Annual Canadian Center for Vaccinology Symposium


This event will take place on April 24th at the Halifax Infirmary and Dalhousie University Student Union Building, respectively. Faculty, researchers, trainees, and members of the community are all invited to take part in this educational event. (There is no fee to attend, but registration is required to obtain CME credits.)

Read More…

Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine

Halifax, Nova Scotia; June 30, 2015 – Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine.

The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for Vaccinology (CCfV) in Halifax and led by Joanne Langley, M.D., will enroll 40 healthy adults who are 50 to 64 years of age. Read More…